WallStSmart

Harte Hanks Inc (HHS)vs3M Company (MMM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

3M Company generates 14853% more annual revenue ($24.95B vs $166.84M). MMM leads profitability with a 13.0% profit margin vs -3.3%. HHS appears more attractively valued with a PEG of 1.19. MMM earns a higher WallStSmart Score of 54/100 (C-).

HHS

Hold

41

out of 100

Grade: D

Growth: 2.0Profit: 3.0Value: 6.7Quality: 7.5
Piotroski: 5/9Altman Z: 13.22

MMM

Buy

54

out of 100

Grade: C-

Growth: 2.7Profit: 7.0Value: 7.3Quality: 5.5
Piotroski: 5/9Altman Z: 2.82
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HHS.

MMMSignificantly Overvalued (-323.6%)

Margin of Safety

-323.6%

Fair Value

$40.80

Current Price

$148.05

$107.25 premium

UndervaluedFair: $40.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HHS2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
13.2210/10

Safe zone — low bankruptcy risk

MMM3 strengths · Avg: 9.0/10
Return on EquityProfitability
75.5%10/10

Every $100 of equity generates 76 in profit

Market CapQuality
$77.25B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.33B8/10

Generating 1.3B in free cash flow

Areas to Watch

HHS4 concerns · Avg: 2.8/10
Market CapQuality
$21.13M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.6%3/10

Operating margin of 2.6%

Debt/EquityHealth
1.093/10

Elevated debt levels

Return on EquityProfitability
-26.6%2/10

ROE of -26.6% — below average capital efficiency

MMM4 concerns · Avg: 2.8/10
Price/BookValuation
16.7x4/10

Trading at 16.7x book value

Revenue GrowthGrowth
2.0%4/10

2.0% revenue growth

EPS GrowthGrowth
-19.9%2/10

Earnings declined 19.9%

Debt/EquityHealth
2.751/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : HHS

The strongest argument for HHS centers on Price/Book, Altman Z-Score. PEG of 1.19 suggests the stock is reasonably priced for its growth.

Bull Case : MMM

The strongest argument for MMM centers on Return on Equity, Market Cap, Free Cash Flow. PEG of 1.43 suggests the stock is reasonably priced for its growth.

Bear Case : HHS

The primary concerns for HHS are Market Cap, Operating Margin, Debt/Equity.

Bear Case : MMM

The primary concerns for MMM are Price/Book, Revenue Growth, EPS Growth. Debt-to-equity of 2.75 is elevated, increasing financial risk.

Key Dynamics to Monitor

HHS profiles as a turnaround stock while MMM is a value play — different risk/reward profiles.

MMM carries more volatility with a beta of 1.13 — expect wider price swings.

MMM is growing revenue faster at 2.0% — sustainability is the question.

MMM generates stronger free cash flow (1.3B), providing more financial flexibility.

Bottom Line

MMM scores higher overall (54/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Harte Hanks Inc

INDUSTRIALS · CONGLOMERATES · USA

Harte Hanks, Inc. is a customer experience company in the United States and internationally. The company is headquartered in Chelmsford, Massachusetts.

Visit Website →

3M Company

INDUSTRIALS · CONGLOMERATES · USA

The 3M Company is an American multinational conglomerate corporation operating in the fields of industry, worker safety, US health care, and consumer goods. The company produces over 60,000 products under several brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical and electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films. It is based in Maplewood, a suburb of Saint Paul, Minnesota.

Visit Website →

Want to dig deeper into these stocks?